ARCHIVES

Bast Named VP For Translational Research And Co-PI Of Core Grant At M. D. Anderson.

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | March 24, 2000

Download PDF Visit The Full Archive

Related Articles

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

“Exciting” Developments In Diagnosis, Screening Methods Reported By Berlin As He Leaves NCI Post

April 11, 1975

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Funding opportunities listed.

January 2, 2004

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982

Control Finally Gets A Leader–Diane Fink–With An In-House Promotion; NCI Says It Will Spend All The Program’s $34 Million

March 1, 1974